CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 1 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $995,000 | -48.5% | 350,336 | -48.1% | 0.02% | -54.5% |
| Q3 2017 | $1,931,000 | +15.8% | 675,000 | 0.0% | 0.03% | +13.8% |
| Q2 2017 | $1,667,000 | -31.6% | 675,000 | 0.0% | 0.03% | -46.3% |
| Q1 2017 | $2,437,000 | +2.0% | 675,000 | 0.0% | 0.05% | +1.9% |
| Q4 2016 | $2,390,000 | -12.4% | 675,000 | 0.0% | 0.05% | -1.9% |
| Q3 2016 | $2,727,000 | -8.0% | 675,000 | 0.0% | 0.05% | -11.5% |
| Q2 2016 | $2,963,000 | +16.1% | 675,000 | 0.0% | 0.06% | +22.0% |
| Q1 2016 | $2,552,000 | -56.6% | 675,000 | +80.0% | 0.05% | -54.5% |
| Q4 2015 | $5,880,000 | +48.7% | 375,000 | 0.0% | 0.11% | +25.0% |
| Q3 2015 | $3,953,000 | -37.3% | 375,000 | +50.0% | 0.09% | -67.5% |
| Q2 2015 | $6,305,000 | – | 250,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 1,025,000 | $24,815,000 | 31.36% |
| TSP Capital Management Group, LLC | 836,342 | $20,248,000 | 8.80% |
| Iguana Healthcare Management, LLC | 200,000 | $4,842,000 | 2.76% |
| First Light Asset Management, LLC | 116,096 | $2,811,000 | 2.38% |
| SECTORAL ASSET MANAGEMENT INC | 2,227,688 | $53,932,000 | 2.33% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 550,735 | $13,334,000 | 2.05% |
| Eventide Asset Management | 257,000 | $6,222,000 | 1.92% |
| Redmile Group, LLC | 397,951 | $9,634,000 | 1.19% |
| ARDSLEY ADVISORY PARTNERS LP | 357,000 | $8,643,000 | 1.15% |
| Rhenman & Partners Asset Management AB | 90,000 | $2,179,000 | 0.85% |